US FDA’s Career Leaders Quietly Emerge As Effective Operators In COVID-19 Response

 
• By Ramsey Baghdadi

FDA medical review leaders have been remarkable on balancing the two challenges of finding treatments for COVID-19 and keeping everything else running on time.

FDABldg1ExteriorWithCircle_1200x675

They were not on the White House podium for the Coronavirus Task Force briefings or on Twitter making breathless predictions about COVID-19.

But the senior leaders overseeing the US Food and Drug Administration’s review centers and their medical teams are demonstrating the...

More from US FDA

More from Agency Leadership